Google donates $2.4 million to support LGBTQ+ movement
by Maria Thomas
Updated Jun 16, 2020
The $1.2 million donation to more than 70 organisations is done via Google.org which are located in cities around the world.
"As diverse as the local communities they serve, these organizations create cherished spaces to embrace our intersections and individuality, organize against injustice, and provide access to services," said Maab Ibrahim Programme Manager, Google.org.
For the most vulnerable LGBTQ+ communities, including Black+ communities experiencing the disproportionate impacts of COVID-19 and racial injustice, these spaces and services are essential.
Every year, an estimated 1.8 million LGBTQ+ youth seriously consider suicide in the US, and the lifeline, text, and chat crisis services at The Trevor Project - a Google.org grantee = are experiencing their highest demand in 22 years.
"The Trevor Project's work is life-saving, which is why we're providing $1.2 million to build on our existing work with them," said Google.
In addition, a new cohort of Google.org Fellows will help The Trevor Project use natural language processing to automate the moderation of crisis content on its online forums and instruct counselors through a virtual conversation simulator training.
The whole world is showing support and embracing the Pride movement with a celebration of colour this month.
Related Articles
- Optical Illusion Brain Test: If you have Sharp Eyes Find the Number 442 in 20 Secs
- London-based firm Nothing to release its Phone (2)
- Covid will continue to cause mini-waves, not become seasonal yet: Scientists
- Hackers offering crypto accounts for as low as $30 on darknet
- Reddit's new feature to allow users to share its content on other platforms
- Surgical masks can help kids fight respiratory infections: Study
- LinkedIn's new AI feature to write messages to hiring team
- Microsoft introduces Xbox Game Pass' new Friend Referral programme
- Disbursed over Rs 31 cr in claims to delivery partners in FY22-23: Swiggy
- India emerging as favourable destination for clinical trials: Report